Carboplatin Side Effects
Applies to carboplatin: intravenous powder for solution, intravenous solution.
Important warnings
This medicine can cause some serious health issues
Intravenous route (solution; powder for solution)
Bone marrow suppression with carboplatin is dose-related and may be severe, resulting in infection and/or bleeding.
Anemia may be cumulative and may require transfusion support. Vomiting is another frequent drug-related side effect.
Anaphylactic-like reactions to carboplatin have been reported and may occur within minutes of carboplatin administration.
Precautions
It is very important that your doctor check your progress at regular visits to make sure that this medicine is working properly and to check for unwanted effects.
While you are being treated with carboplatin, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Carboplatin may lower your body's resistance and there is a chance you might get the infection the immunization is meant to prevent. In addition, other persons living in your household should not take oral polio vaccine since there is a chance they could pass the polio virus on to you. Also, avoid persons who have taken oral polio vaccine within the last several months. Do not get close to them, and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth.
Carboplatin can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
- If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.
- Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in urine or stools; or pinpoint red spots on your skin.
- Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your health care professional before having any dental work done.
- Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.
- Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.
- Avoid contact sports or other situations where bruising or injury could occur.
Serious side effects of carboplatin
Along with its needed effects, carboplatin may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Also, because of the way these medicines act on the body, there is a chance that they might cause other unwanted effects that may not occur until months or years after the medicine is used. These delayed effects may include certain types of cancer, such as leukemia. Discuss these possible effects with your doctor.
Check with your doctor as soon as possible if any of the following side effects occur while taking carboplatin:
More common side effects
- pain at place of injection
Less common side effects
- black, tarry stools
- blood in urine or stools
- cough or hoarseness, accompanied by fever or chills
- fever or chills
- lower back or side pain, accompanied by fever or chills
- numbness or tingling in fingers or toes
- painful or difficult urination, accompanied by fever or chills
- pinpoint red spots on skin
- skin rash or itching
- unusual bleeding or bruising
- unusual tiredness or weakness
Rare side effects
- blurred vision
- ringing in ears
- sores in mouth and on lips
- wheezing
Other side effects of carboplatin
Some side effects of carboplatin may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- nausea and vomiting
- unusual tiredness or weakness
Less common side effects
- constipation or diarrhea
- loss of appetite
This medicine may cause a temporary loss of hair in some people. After treatment with carboplatin has ended, normal hair growth should return.
For healthcare professionals
Applies to carboplatin: intravenous powder for injection, intravenous solution.
Hematologic adverse events
- Very common (10% or more): Leukopenia (98%), neutropenia (97%), anemia (91%), thrombocytopenia (70%), bleeding (10%)
- Rare (less than 0.1%): Febrile neutropenia
- Frequency not reported: Bone marrow failure, hemolytic-uremic syndrome[Ref]
Gastrointestinal
- Very common (10% or more): Nausea (93%), vomiting (84%), adverse GI effects (50%), abdominal pain
- Common (1% to 10%): Mucositis, diarrhea, constipation
- Frequency not reported: Stomatitis, pancreatitis[Ref]
Nervous system
- Very common (10% or more): Central neurotoxicity (26%), peripheral neuropathy (15%)
- Common (1% to 10%): Other sensory side effects, paresthesia, decrease of osteotendinous reflexes, sensory disturbance, dysgeusia
- Frequency not reported: Cerebrovascular accident, reversible posterior leukoencephalopathy syndrome (RPLS)[Ref]
Hepatic
- Very common (10% or more): Alkaline phosphatase elevations (29%), SGOT elevations (20%), aspartate aminotransferase increased, liver function test abnormal
- Common (1% to 10%): Bilirubin elevations[Ref]
Renal
- Very common (10% or more): Blood urea elevations (17%), creatinine renal clearance decreased[Ref]
Other
- Very common (10% or more): Pain (44%), asthenia (41%), ototoxicity (12%)
- Common (1% to 10%): Asthenia
- Frequency not reported: Malaise[Ref]
Hypersensitivity
- Common (1% to 10%): Hypersensitivity, anaphylactoid type reaction[Ref]
Metabolic
- Very common (10% or more): Magnesium loss (61%), potassium loss (16%), calcium loss (16%), sodium loss (10%)
- Rare (less than 0.1%): Hyponatremia
- Frequency not reported: Dehydration, anorexia, tumor lysis syndrome[Ref]
Ocular
- Rare (less than 0.1%): Visual disturbance (including rare cases of loss of vision)[Ref]
Immunologic
- Very common (10% or more): Infection (14%)
Local
- Frequency not reported: Injection site necrosis, injection site reaction, injection site extravasation, injection site erythema
Musculoskeletal
- Common (1% to 10%): Musculoskeletal disorder[Ref]
Genitourinary
- Common (1% to 10%): Urogenital disorder[Ref]
Oncologic
- Frequency not reported: Neoplasms (e.g., benign, malignant, unspecified) including cysts and polyps[Ref]
Respiratory
- Common (1% to 10%): Respiratory disorder, interstitial lung disease, bronchospasm
- Frequency not reported: Pneumonia[Ref]
Cardiovascular
- Common (1% to 10%): Cardiovascular disorder
- Frequency not reported: Cardiac failure, embolism, hypertension, hypotension[Ref]
Dermatologic
- Very common (10% or more): Alopecia (49%), skin disorder
- Frequency not reported: Urticaria, rash, erythema, pruritus[Ref]
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Paclitaxel
Paclitaxel systemic is used for breast cancer, breast cancer, adjuvant, breast cancer, metastatic ...
Cyclophosphamide
Cyclophosphamide systemic is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia ...
Bevacizumab
Bevacizumab injection is a targeted cancer drug used to treat types of non-small cell lung cancer ...
Fluorouracil
Fluorouracil systemic is used for anal cancer, breast cancer, breast cancer, palliative, cancer ...
References
1. Kerr DJ, Lewis C, O'Neill B, et al. (1990) "The myelotoxicity of carboplatin is influenced by the time of its administration." Hematol Oncol, 8, p. 59-63
2. "Multum Information Services, Inc. Expert Review Panel"
3. (2001) "Product Information. Paraplatin (carboplatin)." Bristol-Myers Squibb
4. (2019) "Product Information. Carboplatin (carboplatin)." Sun Pharmaceutical Industries
5. McDonald BR, Kirmani S, Vasquez M, Mehta R (1991) "Acute renal failure associated with the use of intraperitoneal carboplatin: a report of two cases and review of the literature." Am J Med, 90, p. 386-91
6. Deray G, Ben-Othman T, Brillet G, Baumelou B, Gabarre J, Baumelou A, Binet JL, Jacobs C (1990) "Carboplatin-induced acute renal failure." Am J Nephrol, 10, p. 431-2
7. Mulder PO, Sleijfer DT, de Vries EG, Uges DR, Mulder NH (1988) "Renal dysfunction following high-dose carboplatin treatment." J Cancer Res Clin Oncol, 114, p. 212-4
8. Chevreau C, Thomas F, Couteau C, Dalenc F, Mourey L, Chatelut E (2005) "Ototoxicity of high-dose Carboplatin." J Clin Oncol, 23, p. 3649-50
9. Windom HH, McGuire WP, Hamilton RG, Adkinson NF (1992) "Anaphylaxis to carboplatin: a new platinum chemotherapeutic agent." J Allergy Clin Immunol, Oct, p. 681-3
10. Weidmann B, Mulleneisen N, Bojko P, Niederle N (1994) "Hypersensitivity reactions to carboplatin. Report of two patients, review of the literature, and discussion of diagnostic procedures and management." Cancer, 73, p. 2218-22
11. Planner RS, Weerasiri T, Timmins D, Grant P (1991) "Hypersensitivity reactions to carboplatin." J Natl Cancer Inst, 83, p. 1763-4
12. Tonkin KS, Rubin P, Levin L (1993) "Carboplatin hypersensitivity: case reports and review of the literature." Eur J Cancer, 29a, p. 1356-7
13. Sood AK, Gelder MS, Huang SW, Morgan LS (1995) "Anaphylaxis to carboplatin following multiple previous uncomplicated courses." Gynecol Oncol, 57, p. 131-2
14. Broome CB, Schiff RI, Friedman HS (1996) "Successful desentization to carboplatin in patients with systemic hypersensitivity reactions." Med Pediatr Oncol, 26, p. 105-10
15. O'Brien MER, Tonge K, Blake P, et al. (1991) "Blindness associated with high-dose carboplatin." Lancet, 339, p. 558
Frequently asked questions
- Why give Taxol (Paxel) before carboplatin?
- What is TCHP chemotherapy and how is it used?
- How does carboplatin stop cancer?
- Does carboplatin cause neuropathy?
More about carboplatin
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (5)
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Carboplatin side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.